JP2024501388A5 - - Google Patents

Info

Publication number
JP2024501388A5
JP2024501388A5 JP2023563917A JP2023563917A JP2024501388A5 JP 2024501388 A5 JP2024501388 A5 JP 2024501388A5 JP 2023563917 A JP2023563917 A JP 2023563917A JP 2023563917 A JP2023563917 A JP 2023563917A JP 2024501388 A5 JP2024501388 A5 JP 2024501388A5
Authority
JP
Japan
Application number
JP2023563917A
Other languages
Japanese (ja)
Other versions
JP2024501388A (ja
JPWO2022147039A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/065386 external-priority patent/WO2022147039A1/en
Publication of JP2024501388A publication Critical patent/JP2024501388A/ja
Publication of JP2024501388A5 publication Critical patent/JP2024501388A5/ja
Publication of JPWO2022147039A5 publication Critical patent/JPWO2022147039A5/ja
Pending legal-status Critical Current

Links

JP2023563917A 2020-12-29 2021-12-28 Rnaの送達のための組成物および方法 Pending JP2024501388A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063131528P 2020-12-29 2020-12-29
US63/131,528 2020-12-29
PCT/US2021/065386 WO2022147039A1 (en) 2020-12-29 2021-12-28 Compositions and methods for delivery of rna

Publications (3)

Publication Number Publication Date
JP2024501388A JP2024501388A (ja) 2024-01-11
JP2024501388A5 true JP2024501388A5 (https=) 2024-12-23
JPWO2022147039A5 JPWO2022147039A5 (https=) 2024-12-23

Family

ID=82261084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023563917A Pending JP2024501388A (ja) 2020-12-29 2021-12-28 Rnaの送達のための組成物および方法

Country Status (8)

Country Link
US (1) US20250263678A1 (https=)
EP (1) EP4271389A4 (https=)
JP (1) JP2024501388A (https=)
CN (1) CN116916936A (https=)
AU (1) AU2021413753A1 (https=)
CA (1) CA3206970A1 (https=)
IL (1) IL304123A (https=)
WO (1) WO2022147039A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024094211A1 (zh) * 2022-11-06 2024-05-10 斯微(上海)生物科技股份有限公司 一种脂质组合物
EP4692345A1 (en) * 2023-03-29 2026-02-11 Shenzhen Shenxin Biotechnology Co., Ltd. Polynucleotide molecule comprising poly(a) and use thereof
WO2025049632A1 (en) * 2023-08-29 2025-03-06 Rejuvenation Technologies Inc. Compositions and methods for broad delivery of rna to tissue
JP2026066951A (ja) * 2024-10-07 2026-04-17 Agc株式会社 核酸送達用脂質ナノ粒子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3047667T3 (en) * 2013-02-22 2025-12-04 Univ Leland Stanford Junior Methods relating to telomere extension
EP3087193A4 (en) * 2013-12-27 2017-08-09 Teloregen, Inc. Compositions and methods for providing active telomerase to cells in vivo
US20180360924A1 (en) * 2015-11-25 2018-12-20 The Methodist Hospital System Telomere extension and anti-inflammatory agents for cell regeneration
JP2019529499A (ja) * 2016-09-30 2019-10-17 ベイラー カレッジ オブ メディスンBaylor College Of Medicine 組織指向性発現を用いた抗体ベースの遺伝子治療
WO2019188867A1 (ja) * 2018-03-27 2019-10-03 日油株式会社 細胞内動態を改善した新規カチオン性脂質
JP7304421B2 (ja) * 2018-10-05 2023-07-06 アールエヌエージーン インコーポレイテッド 標的細胞特異的に結合して多重免疫機能が強化されたキメラ抗原及びこの用途
CA3118034A1 (en) * 2018-12-21 2020-06-25 Curevac Ag Rna for malaria vaccines
EP3906039A4 (en) * 2019-01-04 2023-01-18 Oncorus, Inc. ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE

Similar Documents

Publication Publication Date Title
JP2024501388A5 (https=)
CN305802719S (https=)
CN305558883S (https=)
CN305536692S (https=)
CN305535970S (https=)
CN305534002S (https=)
CN305692568S (https=)
CN305691070S (https=)
CN305680838S (https=)
CN305533323S (https=)
CN305727317S (https=)
CN305531537S (https=)
CN305531435S (https=)
CN305531179S (https=)
CN305530148S (https=)
CN305529969S (https=)
CN305528489S (https=)
CN305527547S (https=)
CN305670904S (https=)
CN306934844S (https=)
CN305740600S (https=)
CN305710984S (https=)
CN305834166S (https=)
CN305656462S (https=)
CN305697220S (https=)